NCT00549861View on ClinicalTrials.gov

Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Cardiomyopathy, DilatedCardiomyopathies, Secondary
Interventions
PROCEDURE

Cardiac Magnetic Resonance study

Cardiac MRI study

Trial Locations (1)

T2N 2T9

Stephenson CMR Centre at Foothills Medical Centre, University of Calgary, Calgary

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Oliver Strohm

OTHER

NCT00549861 - Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR | Biotech Hunter | Biotech Hunter